agent

(redirected from immunosuppressive agent)
Also found in: Dictionary, Thesaurus, Medical, Legal, Financial.
Related to immunosuppressive agent: Immunosuppressive medication

agent

a person representing a business concern, esp a travelling salesman

Agent

 

in Soviet civil law, a party in a contract of agency. The agent’s duties include the performance of specified legal acts, for example, contracts of sale and management of property, in the name of and on the account of a principal party. The agent may be a legally competent (sui juris) citizen or a legal person (if this is allowed by the latter’s charter or statute). The actions performed by the agent directly generate, change, or extinguish rights and obligations of the principal.

The agent is bound to perform the agency in exact conformity with the principal’s instructions, carry out the agency personally, although in instances provided for by law the responsibilities may be transferred to another person (art. 68 of the RSFSR Civil Code), inform the principal upon demand of progress in performing the agency, submit a report on performance of the agency, and transfer to the principal any property obtained in connection with performance of the agency.

agent

One who is empowered to enter into binding transactions on behalf of another (usually called the principal).

agent

(networking)
In the client-server model, the part of the system that performs information preparation and exchange on behalf of a client or server. Especially in the phrase "intelligent agent" it implies some kind of automatic process which can communicate with other agents to perform some collective task on behalf of one or more humans.

agent

A software routine that waits in the background and performs an action when a specified event occurs. For example, agents could transmit a summary file on the first day of the month or monitor incoming data and alert the user when a certain transaction has arrived. Agents are also called "intelligent agents," "personal agents" and "bots." See mobile agent, bot and workflow.
References in periodicals archive ?
8] In our case, prednisolone was transiently, but incompletely, effective so an immunosuppressive agent was also administered.
All patients with diabetes could be eligible if we are able to develop safer and better immunosuppressive agents to achieve tolerance.
Other studies are under way to determine whether daily omega-3 therapy lessens the side effects of cyclosporine, a commonly prescribed immunosuppressive agent used in kidney transplantation.
The type of primary immunosuppressive agent used in transplantation influenced the predominant clinical manifestation of cryptococcosis.
Toward this end, the investigators recruited 50 female patients aged 18-3 5 years who fulfilled at least four American College of Rheumatology criteria for SLE, and who had received a stable dose of prednisolone or other immunosuppressive agent within the previous 3 months, to participate in the prospective investigation.
The increased use of tacrolimus has been propelled by the near consensus in the transplant community that it is a more potent immunosuppressive agent than cyclosporine, associated with better renal function, easier to dose and has less cosmetic side effects, thereby diminishing the risk of non-compliance.
Advagraf(R) is a once-daily formulation of Prograf(R) (tacrolimus, twice-daily formulation), a leading immunosuppressive agent of care in the prevention of organ rejection, developed by Astellas.
Sirolimus is the active pharmaceutical ingredient in two products approved by the European Medicines Agency (EMA) and the US Food and Drug Administration (FDA), specifically, Rapamune[R], an immunosuppressive agent used in renal transplant patients, and the CYPHER[R] Sirolimus-eluting Coronary Stent approved for improving coronary luminal diameter in patients with symptomatic ischemic disease.
Advagraf(R) is a once-daily formulation of Prograf(R) (tacrolimus, twice-daily formulation), the leading immunosuppressive agent developed by Astellas.
One of these is methotrexate, an immunosuppressive agent, whose fewer side effects have made it the favored drug of many arthritis specialists.
Sirolimus is the active pharmaceutical ingredient in 2 products approved by the EMA and the US Food and Drug Administration (FDA), specifically Rapamune[R], an immunosuppressive agent used in renal transplant patients, and the CYPHER[R] Sirolimus-eluting Coronary Stent approved for improving coronary luminal diameter in patients with symptomatic ischemic disease.
Everolimus, a novel proliferation inhibitor and immunosuppressive agent, may suppress cardiac allograft vasculopathy.